+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vascular Graft Market Research Report by Product, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4986094
  • Report
  • July 2021
  • Region: Global
  • 198 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Vascular Graft Market will Grow to USD 5,267.06 Million by 2026, at a CAGR of 7.79%

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cardinal Health Inc.
  • CryoLife, Inc.
  • Getinge AB
  • Japan Lifeline Co., Ltd
The Global Vascular Graft Market size was estimated at USD 3,357.92 Million in 2020 and expected to reach USD 3,608.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.79% to reach USD 5,267.06 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vascular Graft to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Vascular Graft Market was studied across Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft, and Peripheral Vascular Grafts.
  • Based on Raw Material, the Vascular Graft Market was studied across Biological Materials, Polyester, Polytetrafluoroethylene, and Polyurethane.
  • Based on Application, the Vascular Graft Market was studied across Aneurysm, Cardiovascular, Diabetes, Kidney Failure, and Vascular Occlusion.
  • Based on End User, the Vascular Graft Market was studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, the Vascular Graft Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vascular Graft Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vascular Graft Market, including Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn Bhd, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV., Japan Lifeline Co., Ltd, Laboratory Corporation of America Holdings, Lemaitre Vascular, Inc., Lombard Medical, Inc., Maquet Holding B.V. & Co. Kg, Medtronic PLC, Shanghai Suokang Medical Implants Co., Ltd., Terumo Corporation, Vascular Graft Solutions Ltd, Vygon SA, and W. L. Gore & Associates, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Vascular Graft Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Graft Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Graft Market?
4. What is the competitive strategic window for opportunities in the Global Vascular Graft Market?
5. What are the technology trends and regulatory frameworks in the Global Vascular Graft Market?
6. What is the market share of the leading vendors in the Global Vascular Graft Market?
7. What modes and strategic moves are considered suitable for entering the Global Vascular Graft Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cardinal Health Inc.
  • CryoLife, Inc.
  • Getinge AB
  • Japan Lifeline Co., Ltd
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Raw Material Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number chronic diseases worldwide
5.1.1.2. Growing number of end-stage renal disorders in developing economies
5.1.1.3. Surge prevalence of end stage renal disease (ESRD)
5.1.2. Restraints
5.1.2.1. High treatment cost and infections associated with vascular grafts
5.1.3. Opportunities
5.1.3.1. Increasing patients awareness and high demand from developing countries
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and low penetration of reimbursement
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Vascular Graft Market, by Product
6.1. Introduction
6.2. Coronary Artery By-Pass Graft
6.3. Endovascular Stent Graft
6.4. Hemodialysis Access Graft
6.5. Peripheral Vascular Grafts

7. Vascular Graft Market, by Raw Material
7.1. Introduction
7.2. Biological Materials
7.3. Polyester
7.4. Polytetrafluoroethylene
7.5. Polyurethane

8. Vascular Graft Market, by Application
8.1. Introduction
8.2. Aneurysm
8.3. Cardiovascular
8.4. Diabetes
8.5. Kidney Failure
8.6. Vascular Occlusion

9. Vascular Graft Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital

10. Americas Vascular Graft Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Vascular Graft Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Vascular Graft Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Affluent Medical
14.3. B. Braun Melsungen AG
14.4. Becton, Dickinson and Company
14.5. BIOVIC Sdn Bhd
14.6. Boston Scientific Corporation
14.7. Cardinal Health Inc.
14.8. Cook Medical, Inc.
14.9. CryoLife, Inc.
14.10. Endologix Inc.
14.11. Getinge AB
14.12. Heart Medical Europe BV.
14.13. Japan Lifeline Co., Ltd
14.14. Laboratory Corporation of America Holdings
14.15. Lemaitre Vascular, Inc.
14.16. Lombard Medical, Inc.
14.17. Maquet Holding B.V. & Co. Kg
14.18. Medtronic PLC
14.19. Shanghai Suokang Medical Implants Co., Ltd.
14.20. Terumo Corporation
14.21. Vascular Graft Solutions Ltd
14.22. Vygon SA
14.23. W. L. Gore & Associates, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL VASCULAR GRAFT MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2020 (USD MILLION)
FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR GRAFT MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL VASCULAR GRAFT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFTS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2020 VS 2026 (%)
FIGURE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2020 VS 2026 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2026
FIGURE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2026
FIGURE 35. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 46. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2026
FIGURE 48. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. AMERICAS VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. ARGENTINA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. BRAZIL VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. CANADA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. MEXICO VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. AUSTRALIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. CHINA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. INDIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. INDONESIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. JAPAN VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. MALAYSIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. PHILIPPINES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. SINGAPORE VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. THAILAND VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. FRANCE VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. GERMANY VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. ITALY VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. NETHERLANDS VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. QATAR VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. RUSSIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. SPAIN VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. GLOBAL VASCULAR GRAFT MARKET: FPNV POSITIONING MATRIX
FIGURE 82. GLOBAL VASCULAR GRAFT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VASCULAR GRAFT MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL VASCULAR GRAFT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. ARGENTINA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. CANADA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. MEXICO VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. AUSTRALIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. CHINA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. INDIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDONESIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. JAPAN VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. MALAYSIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. PHILIPPINES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SINGAPORE VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. THAILAND VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. FRANCE VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. GERMANY VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. ITALY VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. NETHERLANDS VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. QATAR VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. RUSSIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SPAIN VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. GLOBAL VASCULAR GRAFT MARKET: SCORES
TABLE 53. GLOBAL VASCULAR GRAFT MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL VASCULAR GRAFT MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL VASCULAR GRAFT MARKET: RANKING
TABLE 56. GLOBAL VASCULAR GRAFT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL VASCULAR GRAFT MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL VASCULAR GRAFT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL VASCULAR GRAFT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL VASCULAR GRAFT MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL VASCULAR GRAFT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL VASCULAR GRAFT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn Bhd
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV.
  • Japan Lifeline Co., Ltd
  • Laboratory Corporation of America Holdings
  • Lemaitre Vascular, Inc.
  • Lombard Medical, Inc.
  • Maquet Holding B.V. & Co. Kg
  • Medtronic PLC
  • Shanghai Suokang Medical Implants Co., Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd
  • Vygon SA
  • W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll